RxDoctor Payments Data

Carlos Ayala, MD

Otolaryngology/Facial Plastic Surgery · McAllen, TXNPI 1881688174

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,874 of the $3,880 with a category attached, or 74.1%. 18 manufacturers reported payments, led by Medical Device Business Services, Inc. at 25.9% of the total. Reporting peaked in 2019 at $1,712 and has fallen 57.0% since, to $737 in 2025.

$3,880in general payments, 2019–2025

Across 77 payments — averaging $50.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medical Device Business Services, Inc.$1K
  • Medtronic$715
  • Acclarent, Inc$423
  • Optinose US, Inc.$299
  • Regeneron Healthcare Solutions, Inc.$245
  • Galderma Laboratories, L.p.$203
  • plus $990 from 12 others

What the payments were for

  • Travel & lodging$1,00626%
  • Food & beverage$2,87474%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,880 in reported general payments places this provider in the 70th percentile of 51 otolaryngology/facial plastic surgery providers in Texas.

See all otolaryngology/facial plastic surgery providers in Texas

Medicare billing

Part B allowed, 2024
$52,924
Medicare patients
21
Services billed
982

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Epinephrine11$1,933
Fluticasone Propionate28$534
Mupirocin12$86
Cephalexin15$57

Paid to pharmacies, not to this prescriber.

Other otolaryngology/facial plastic surgery in McAllen

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →